JAMA Network Home
Sign In
Original Investigation

Acute Angle Closure Incidence in a Large Countywide Safety Net Teleretinal Screening Program

JAMA Ophthalmology 10.1001/jamaophthalmol.2025.3162

September 18, 2025 at 11:00 AM EDT

Read the full article

What is the incidence of acute angle closure (AAC) after pharmacologic pupillary dilation in a large county-wide teleretinal diabetic retinopathy screening program?In this cohort study of 84 008 patients and 168 796 dilations, there were 4 cases of medical record–confirmed AAC. AAC incidence was 2.4 per 100 000 dilations or 4.8 per 100 000 patients.These results support the safety of pharmacologic dilation in primary care–based teleretinal screening programs.

Corresponding Author: Lauren P. Daskivich, MD, MSHS, Ophthalmology and Eye Health Programs, Department of Health Services, Los Angeles County, 313 N Figueroa St, Ste 904C, Los Angeles, CA 90012 (lpdaskivich@dhs.lacounty.gov).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2025.3162?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091825

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks